292 related articles for article (PubMed ID: 24431264)
21. Noninvasive fetal blood grouping: present and future.
Daniels G; Finning K; Martin P
Clin Lab Med; 2010 Jun; 30(2):431-42. PubMed ID: 20513561
[TBL] [Abstract][Full Text] [Related]
22. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.
Blomme S; Nollet F; Rosseel W; Bogaard N; Devos H; Emmerechts J; Cauwelier B
Transfusion; 2022 May; 62(5):1103-1109. PubMed ID: 35352833
[TBL] [Abstract][Full Text] [Related]
23. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
[TBL] [Abstract][Full Text] [Related]
24. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
25. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
26. Noninvasive fetal RhCE genotyping from maternal blood.
Geifman-Holtzman O; Grotegut CA; Gaughan JP; Holtzman EJ; Floro C; Hernandez E
BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
[TBL] [Abstract][Full Text] [Related]
27. Fetal blood group genotyping.
Denomme GA; Fernandes BJ
Transfusion; 2007 Jul; 47(1 Suppl):64S-8S. PubMed ID: 17593289
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
Bianchi DW; Avent ND; Costa JM; van der Schoot CE
Obstet Gynecol; 2005 Oct; 106(4):841-4. PubMed ID: 16199645
[TBL] [Abstract][Full Text] [Related]
29. [Genetic analysis of the fetus using maternal blood].
Costa JM; Gautier E; Benachi A
Gynecol Obstet Fertil; 2004; 32(7-8):646-50. PubMed ID: 15450264
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
Hyland CA; O'Brien H; Flower RL; Gardener GJ
Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
[TBL] [Abstract][Full Text] [Related]
31. Fetal RhD genotyping by analysis of maternal blood. A case report.
Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
[TBL] [Abstract][Full Text] [Related]
32. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
[TBL] [Abstract][Full Text] [Related]
36. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
[TBL] [Abstract][Full Text] [Related]
37. Prenatal determination of fetal RhD type by DNA amplification.
Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP
N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334
[TBL] [Abstract][Full Text] [Related]
38. Lessons learned from the implementation of non-invasive fetal RHD screening.
Clausen FB
Expert Rev Mol Diagn; 2018 May; 18(5):423-431. PubMed ID: 29616835
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
40. Non-invasive antenatal RHD typing.
Van der Schoot CE; Soussan AA; Koelewijn J; Bonsel G; Paget-Christiaens LG; de Haas M
Transfus Clin Biol; 2006; 13(1-2):53-7. PubMed ID: 16564727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
